A thrombotic complication of COVID-19: cerebral ischaemia in the intensive care unit

A thrombotic complication of COVID-19: cerebral ischaemia in the intensive care unit

COVID-19 may predispose to thromboembolic disease due to severe inflammation, hypoxia, and immobilisation [1]. The severe hypercoagulable state of COVID-19 patients includes systemic micro- and macrovascular thrombosis. Anticoagulant therapy, mainly with low-molecular-weight heparin, appears to be a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of medical sciences. Atherosclerotic diseases 2020-01, Vol.5 (1), p.224-225
Hauptverfasser: Şahin, Ayça Sultan, Irak, Kader, Kaya, Ebru, Ozkan, Sureyya, Baskan, Fikret
Format: Artikel
Sprache:eng
Schlagworte:
Letter to the Editor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:COVID-19 may predispose to thromboembolic disease due to severe inflammation, hypoxia, and immobilisation [1]. The severe hypercoagulable state of COVID-19 patients includes systemic micro- and macrovascular thrombosis. Anticoagulant therapy, mainly with low-molecular-weight heparin, appears to be associated with better prognosis in severe COVID-19 patients [2].
ISSN:2451-0629
2451-0629
DOI:10.5114/amsad.2020.98920